v3.26.3
Discontinuation of M6 Product Lines and Held-for-Sale Assets (Tables)
 9 Months Ended
Sep. 30, 2026
Discontinuation of Product Line and Held for Sale Assets [Abstract]  
Summary of Impairment Charges A summary of impairment charges recognized during the three and nine months ended September 30, 2025, and the associated financial statement lines in which such costs were recognized is shown in the table below. All such changes are included within the Company's Global Spine reporting segment. All related inventory; property, plant, and equipment; and intangible asset balances were fully impaired in the prior year; therefore, there were no further impairments recorded on these assets in the current year.

(Unaudited, U.S. Dollars, in thousands)

Financial Statement Line Item

Three Months Ended September 30, 2025

 

 

Nine Months Ended September 30, 2025

 

Inventory reserve charges

Cost of sales

$

—

 

 

$

11,251

 

Impairment of property, plant, and equipment

Operating expenses

 

—

 

 

 

6,834

 

Impairment of developed technology intangible asset

Acquisition-related amortization, impairment, and remeasurement

 

—

 

 

 

14,097

 

Loss on M6 inventories and long-lived assets held for sale

$

—

 

 

$

32,182